These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 33034846)

  • 1. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond.
    Brown EG; Goldman SM
    Neurotherapeutics; 2020 Oct; 17(4):1406-1417. PubMed ID: 33034846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial treatment: the potential application for Parkinson's disease.
    Fang X
    Neurol Sci; 2019 Jan; 40(1):51-58. PubMed ID: 30415447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
    Alfonsetti M; Castelli V; d'Angelo M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy.
    Kang Y; Kang X; Zhang H; Liu Q; Yang H; Fan W
    ASN Neuro; 2021; 13():17590914211016217. PubMed ID: 34053243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
    Pavan S; Prabhu AN; Prasad Gorthi S; Das B; Mutreja A; Shetty V; Ramamurthy T; Ballal M
    Folia Microbiol (Praha); 2022 Oct; 67(5):693-706. PubMed ID: 35583791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.
    Lorente-Picón M; Laguna A
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33804226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
    Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
    Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human microbiome restoration and safety.
    Daliri EB; Tango CN; Lee BH; Oh DH
    Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype?
    Van Laar T; Boertien JM; Herranz AH
    J Parkinsons Dis; 2019; 9(s2):S371-S379. PubMed ID: 31609702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review.
    Mincic AM; Antal M; Filip L; Miere D
    Clin Nutr; 2024 Jul; 43(7):1832-1849. PubMed ID: 38878554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway.
    Jia X; Chen Q; Zhang Y; Asakawa T
    Front Cell Infect Microbiol; 2023; 13():1296713. PubMed ID: 38173790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and intestinal dysbiosis in Parkinson's disease.
    Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
    Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Microbiome and Antibiotics in Autoimmune Diseases.
    Vangoitsenhoven R; Cresci GAM
    Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
    Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
    Front Immunol; 2022; 13():937555. PubMed ID: 35812394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.